Asthma and asthma severity among african american adults in the jackson heart study

Journal of Asthma

Volumn 46, Issue 4, 2009, Pages 421-428

  Hickson, Demarc A ^a,b,g   Wilhite, Rachel L ^b,c   Petrini, Marcy F ^d   White, Wendy B ^e   Burchfiel, Cecil ^f  

^a JACKSON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^e TOUGALOO COLLEGE   (United States)

^f NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^g NONE   (United States)

Author keywords

African Americans; Asthma; Asthma severity; Jackson Heart Study; Wheezing

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE; HYDROCORTISONE; IPRATROPIUM BROMIDE; METHYLPREDNISOLONE; PREDNISOLONE; SALBUTAMOL; SALMETEROL; THEOPHYLLINE;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASTHMA; CLINICAL EXAMINATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; HYDROCORTISONE BLOOD LEVEL; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; RISK FACTOR; SOCIOECONOMICS; SPIROMETRY; STRESS; WHEEZING; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; COHORT ANALYSIS; ETHNOLOGY; HOSPITALIZATION; LUNG FUNCTION TEST; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROBABILITY; PROGNOSIS; RISK; RISK ASSESSMENT; SEX RATIO; SMOKING; STATISTICAL MODEL; STATISTICS; SURVIVAL RATE; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ASTHMA; COHORT STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; ODDS RATIO; PREVALENCE; PROBABILITY; PROGNOSIS; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SMOKING; SPIROMETRY; SURVIVAL RATE; UNITED STATES; YOUNG ADULT;

EID: 67649779923     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900902846307     Document Type: Article

References (45)

1. Mannino DM, Homa DM, Pertowski CA, Ashizawa A, Nixon LL, Johnson CA, Ball LB, Jack E, Kang DS. Surveillance for asthma - United States, 1960-1995. In: Surveillance Summaries, April 24, 1998. MMWR 1998; 47(SS-5):1-27.
2. Mannino DM, Homa DM, Akinbami LJ, Moorman JE, Geynn C, Redd SC. Surveillance for asthma - United States, 1980-1999. In: Surveillance Summaries, March 29, 2002. MMWR 2002; 51(SS-5):1-13.
3. Moorman JE, Rudd RA, Johnson CA, King M, Minor P, Bailey C, Scalia MR, Akinbami LJ. National Surveillance for Asthma - United States, 1980-2004. In Surveillance Summaries, October 19, 2007. MMWR 2007; 56(SS-08):1-14; 18-54.
4. Arif AA, Delclos GL, Lee ES, Tortolero SR, Whitehead LW. Prevalence and risk factors of asthma and wheezing among US adults: an analysis of the NHANES III data. Eur Respir J 2003; 21:827-833.
5. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999; 159:179-187.
6. Hankinson JL, Kinsley KB, Wagner GR. Comparison of spirometric reference values for Caucasian and African American blue-collar workers. J Occup Environ Med 1996; 38:137-143.
7. Enright PL, Arnold A, Manolio TA, Kuller LH. Spirometry reference values for healthy elderly blacks. The Cardiovascular Health Study Research Group. Chest 1996; 110:1416-1424.
8. Jacobs DR, Nelson ET, Dontas AS, Keller J, Slattery ML, Higgins M. Are race and sex differences in lung function explained by frame size? The CARDIA Study. Am Rev Respir Dis 1992; 146:644-649.
9. Gold DR, Wright R. Population disparities in asthma. Ann Rev Pub Heal 2005; 26:89-113.
10. Ford JG, McCaffrey MA. Understanding disparities in asthma outcomes among African Americans. Clin Chest Med 2006; 27:423-430.
11. Shanawani H. Health disparities and differences in asthma: concepts and controversies. Clin Chest Med 2006; 27:17-28.
12. US Department of Health and Human Services. Respiratory Diseases [Goal 24]. In: Healthy People 2010 (Conference ed., Vol II). Washington, DC: US Government Printing Office, Nov 2000.
13. Gupta RS, Carrion-Carire V, Weiss KB. The widening black/white gap in asthma hospitalizations and mortality. J Allergy Clin Immunol 2006; 117:351-358.
14. Lethbridge-Ç ejku M, Rose D, Vickerie J. Summary health statistics for U.S. Adults: National Health Interview Survey, 2004. National Center for Health Statistics. Vital Health Stat 2006; 10(228).
15. Rose D, Mannino DM, Leaderer BP. Asthma prevalence among US adults, 1998-2000: role of Puerto Rican ethnicity and behavioral and geographic factors. Am J Public Health 2006; 96:880-888.
16. Barseghian G, Levine R, Epps P. Direct effect of cortisol and cortisone on insulin and glucagon secretion. Endocrinology 1982; 111:1648-1151.
17. Davis WA, Knuiman M, Kendall P, Grange V, Davis TME. Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: The Fremantle Study. Diabetes 2004; 27:752-757.
18. Gencay M, Rüdiger JJ, Tamm M, Solér M, Perruchoud AP, Roth M. Increased frequency of Chlamydia pneumoniae antibodies in patients with asthma. Am J Respir Crit Care Med 2001; 163:1097-1100.
19. Tanaka H, Teramoto S, Oashi K, Saikai T, Tanaka S, Suzuki K, Hashimoto M, Abe S. Effects of candesartan on cough and bronchial hyperrespon-siveness in mildly to moderately hypertensive patients with symptomatic asthma. Circulation 2001; 104:281-285.
20. Au DH, Bryson CL, Fan VS, Udris EM, Curtis JR, McDonell MB, Fihn SD. Beta-blockers as single-agent therapy for hypertension and the risk of mortality among patients with chronic obstructive pulmonary disease. Am J Med 2004; 117:925-931.
21. Taylor HA. The Jackson Heart Study: an overview. Ethn Dis 2005; 15(4 suppl 6):S6-1-3.
22. Fuqua SR, Wyatt SB, Andrew ME, Sarpong DF, Henderson FR, Cunningham MF, Taylor HA. Recruiting African-American research participation in the Jackson Heart Study: methods, response rates, and sample description. Ethn Dis 2005; 15(4 suppl 6):S6-18-29.
23. Wilson JG, Rotimi CN, Ekunwe L, Royal CD, Crump ME, Wyatt SB, Steffes MW, Adeyemo A, Zhou J, Taylor HA, Jaquish C. Study Design for Genetic Analysis in the Jackson Heart Study. Ethn Dis 2005; 15(4 suppl 6):S6-30-37.
24. Taylor HA, Wilson JG, Jones DW, Sarpong DF, Srinivasan A, Garrison RJ, Nelson C, Wyatt SB. Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study. Ethn Dis 2005; 15(4 suppl 6):S6-4-17.
25. Carpenter MA, Crow R, Steffes M, Rock W, Heilbraun J, Evans G, Skelton T, Jensen R, Sarpong D. Laboratory, reading center, and coordinating center data management methods in the Jackson Heart Study. Am J Med Sci 2004; 328:131-144.
26. Payne TJ, Wyatt SB, Moseley TH, Dubbert PM, Guiterrez-Mohammed ML, Calvin RL, Taylor HA, Williams DR. Sociocultural Methods in the Jackson Heart Study: Conceptual and Descriptive Overview. Ethn Dis 2005; 15(4 suppl 6):S6-38-48.
27. Sketris I, Metge C, Ross J, MacCara M. The use of the World Health Organization anatomical therapeutic chemical/defined daily dose methodology in Canada. Drug Inform J 2004; 38:1-8.
28. CSTE Position Statement 1998-EH/CD 1. Asthma surveillance and case definition. CSTE Annual Meeting (Accessed January 12, 2009).
29. Enright PL, McClelland RL, Newman AB, Gottlieb DJ, Lebowitz MD. Underdiagnosis and undertreatment of asthma in the elderly. Cardiovascular Health Study Research Group. Chest 1999; 116:603-613.
30. Dixon AE, Yeh F, Welty TK, Rhoades ER, Lee ET, Howard BV, En-right PL; for the Strong Heart Study Research Group. Asthma in American Indian adults: The Strong Heart Study. Chest 2007; 131:1323-1330.
31. Guidelines for the diagnosis and management of asthma. Expert Panel Report 2. National Asthma Education Program, Bethesda, MD; National Heart, Lung, and Blood Institute. National Institute of Health Publication 97-4051. 2002.
32. Standardization of Spirometry: 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152:1107-1136.
33. National Health, Lung, and Blood Institute. JHS manuals of operation: No 8. Pulmonary function assessment. JHS Coordinating Center, Jackson State University, 2001.
34. Barron WG. Urban area criteria for Census 2000. Federal Register 2002; 67:11663-11670.
35. National Institutes of Health. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final. September, 2002. NIH, NHLBI: Bethesda, MD.
36. Self-reported asthma prevalence among adults-United States, 2000. MMWR 2001; 50:682-686.
37. Schanen JG, Iribarren C, Shahar E, Punjabi NM, Rich SS, Sorlie PD, Folsom AR. Asthma and incident cardiovascular disease: the Atherosclerosis Risk in Communities Study. Thorax 2005; 60:633-638.
38. Bucknall CE, Neilly JB, Carter R, Stevenson RD, Semple PF. Bronchial hyperreactivity in patients who cough after receiving angiotension converting enzyme inhibitors. Br Med J 1988; 296:86-88.
39. Williams LK, Joseph CL, Peterson EL, Moon C, Xi H, Krajenta R, Johnson R, Wells K, Booza JC, Tunoeli K, Lafata JE, Johnson CC, Ownby DR, Enberg R, Pladenall M. Race-ethnicity, crime, and other factors associated with adherence to inhaled corticosteroids. J Allergy Clin Immunol 2007; 119:168-175.
40. Krishnan JA, Diette GB, Skinner FA, Clark BD, Steinwachs D, Wu AW. Race and sex differences in consistency of care with national asthma guidelines in managed care organizations. Arch Intern Med 2001; 161:1660-1668.
41. Enright PL, Ward BJ, Tracy BP, Lasser EC. Asthma and its association with cardiovascular disease in the elderly. The Cardiovascular Health Study Research Group. J Asthma 1996; 33:45-53.
42. Yoo Y, Ko HK, Han JJ, Lee Y, Seo KJ, Choung JT, Tockgo YC, Choe J. The prevalence of atopy and asthma among university freshmen in Seoul, Korea: association with obesity. J Asthma 2007; 44: 45-49.
43. Dahl M, Tybjaerg-Hansen A, Vestbo J, Lange P, Nordestgaard BG. Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164:1008-1011.
44. Kan H, Heiss G, Rose KM, Whitsel E, Lurmann F, London SJ. Traffic exposure and lung function in adults: the Atherosclerosis Risk in Communities study. Thorax 2007; 62:873-879.
45. Wyatt SB, Akylbekova EL, Wofford MR, Coady SA, Walker ER, Andrew ME, Keahey WJ, Taylor HA, Jones DW. Prevalence, awareness, treatment, and control of hypertension in the Jackson Heart Study. Hypertension 2008; 51:650-656.